Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Mylan (NQ: MYL)
20.90 USD  -0.38 (-1.79%)
Official Closing Price  /  Updated: 7:08 PM EST, Feb 19, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 5,771,700
Open 21.28
Bid (Size) 20.90 (20)
Ask (Size) 21.13 (40)
Prev. Close 21.28
Today's Range 20.79 - 21.36
52wk Range 16.63 - 32.23
Shares Outstanding 535,496,988
Dividend Yield N/A
Performance
YTD
+1.21%
+1.21%
1 Month
-3.46%
-3.46%
3 Month
+21.23%
+21.23%
6 Month
+9.48%
+9.48%
1 Year
-34.89%
-34.89%
Top News
More News
Mylan to Release 2019 Fourth Quarter, Full Year Results and 2020 Guidance on Feb. 27, 2020
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will release its fourth quarter and full year 2019 financial results, as well as its 2020 financial guidance, on Thursday,... Read More
from PR Newswire
SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
from GlobeNewswire News Releases
More News
Read More
Camden Property Trust Larger Than S&P 500 Component Mylan
category Stocks
from Market News Video
Interesting MYL Put And Call Options For April 3rd
category Stocks
from Market News Video
FDA Approved 1,014 Generic Drugs in 2019
category TEVA , NVS , PFE , and 4 more.
from Motley Fool
Alkermes Targets Bipolar Disorder And Schizophrenia
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
Noteworthy Wednesday Option Activity: COHR, SAFM, MYL
category Stocks
from Market News Video
Better Buy: Pfizer vs. AbbVie
category AGN , MYL , ABBV , and 2 more.
from Motley Fool
Biogen Rallies On Tecfidera Patent Decision
category Benzinga , Patents , Barron's , and 11 more.
from Benzinga
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug?
category BIIB , RHHBY , NVS , and 2 more.
from Motley Fool
Biogen Surges After Winning Crucial Multiple Sclerosis Drug Patent
category Market News , MYL , BIIB
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.